Skip to content

Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest

Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02834065
Enrollment
273
Registered
2016-07-15
Start date
2016-07-28
Completion date
2023-02-28
Last updated
2023-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition Disorders

Keywords

Postoperative Cognitive Decline, Deep Hypothermic Circulatory Arrest, Cardiovascular Surgical Procedures, Functional Magnetic Resonance Imaging, Small Ubiquitin-Related Modifier Proteins

Brief summary

In this study the investigator will randomize 273 subjects to deep (\<20°C), low (20.1°C-24°C), or moderate (24.1°C-28°C) hypothermia during aortic arch surgery with circulatory arrest. The primary purpose of this study is to determine the effect of deep vs low vs moderate hypothermia on neurocognitive function, brain functional connectivity, and leukocyte SUMOylation patterns after surgical circulatory arrest in participants.

Detailed description

Purpose of the Study: Determine the effect of deep vs low vs moderate hypothermia on neurocognitive function, brain functional connectivity, and leukocyte SUMOylation patterns after surgical circulatory arrest. Hypothesis: Deep hypothermia is superior to moderate hypothermia in reducing postoperative cognitive decline and preserving brain functional connectivity and that low hypothermia is non-inferior to deep hypothermia. Design and Procedures: 273 informed and consenting patients who are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi- or total arch replacement via median sternotomy will be randomized to deep (\<20°C), low (20.1°C-24°C), or moderate (24.1°C-28°C) hypothermia during circulatory arrest. Cognitive testing using a standard battery will occur preoperatively (baseline), at 4 weeks, and at 1 year after surgery. Neuroimaging procedures before surgery, and at 4 weeks and 1 year after surgery will consist of high-resolution anatomic, resting-state fMRI (rs-fMRI) and magnetic resonance spectroscopy (MRS) sequences. To characterize leukocyte activation, whole blood will be drawn at 5 time points: at baseline (prior to surgery), before circulatory arrest, 10 minutes after reperfusion, 10 minutes after CPB, and 4 hours after CPB.

Interventions

DEVICECardiopulmonary bypass machine

Routinely used cardiopulmonary bypass machine (standard of care) will be used to initiate circulatory arrest

Sponsors

Emory Healthcare
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
Baylor Scott and White Health
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi- or total arch replacement via median sternotomy

Exclusion criteria

* \< 18 years of age * History of symptomatic cerebrovascular disease, eg, prior stroke with residual deficit * Alcoholism (\> 2 drinks/day) * Psychiatric illness (any clinical diagnoses requiring therapy) * Drug abuse (any illicit drug use in the past 3 months) * Hepatic insufficiency (liver function tests \> 1.5 times the upper limit of normal) * Severe pulmonary insufficiency (requiring home oxygen therapy) * Renal failure (serum creatinine \> 2.0 mg/dL) * Claustrophobic fear * Unable to read and thus unable to complete the cognitive testing * Pregnant women * Patients who score \< 24 on a baseline Mini Mental State Examination (MMSE) or ≥ 27 on the baseline Center for Epidemiological Studies Depression (CES-D) scale * Patients who have pre-existing unsafe implants for 3 Tesla magnetic resonance imaging (MRI). * Patients who have received chemotherapy in the last 12 months. * Patients with COVID-19 diagnosis within the past 12 months

Design outcomes

Primary

MeasureTime frameDescription
Change in short-term cognition as measured by continuous cognitive scoreFrom baseline to 4 weeks post-operativelyTo characterize cognitive function over time while minimizing potential redundancy in the cognitive measures, a factor analysis will be performed on the cognitive test scores from baseline. A continuous change score will be calculated by subtracting the baseline cognitive index (the mean of the domain scores from factor analysis) from the follow-up cognitive index at 4 weeks.

Secondary

MeasureTime frameDescription
Change in long-term cognition as measured by continuous cognitive scoreFrom baseline to 1 year post-operativelyTo characterize cognitive function over time while minimizing potential redundancy in the cognitive measures, a factor analysis will be performed on the cognitive test scores from baseline. A continuous change score will be calculated by subtracting the baseline cognitive index (the mean of the domain scores from factor analysis) from the follow-up cognitive index at 1 year.
Incidence of deliriumUp to post-operative day 3Confusion Assessment Method (CAM)
Change in neurological function as measured by NIHSSAssessed at baseline, post-op day 4, 4 weeks
Change in neuronal metabolismFrom baseline to 4 weeksMagnetic resonance spectra (metabolic peaks) of myoinositol, creatine, choline and N-acetyl aspartate
Change in resting-state functional connectivityFrom baseline to 4 weeks post-operativelyFor the rs-fMRI data, the analyses of primary interest will be the spontaneous, low-frequency fluctuations in the blood oxygen level dependent (BOLD) data of the Default Mode, Salience, and Executive Control Networks.
Change in SUMO 2/3 levelsPre-incision, before circulatory arrest, 10 minutes after reperfusion, 10 minutes after cardiopulmonary bypass, 4 hrs after cardiopulmonary bypass
Change in depression scoreFrom baseline to 4 weeks postoperativelyMeasured by the Center for Epidemiological Studies Depression Scale (CES-D).
Change in anxiety scoreFrom baseline to 4 weeks postoperativelyMeasured by State Trait Anxiety Inventory (STA-I).
Change in SF-36 scoreFrom baseline to 1 year postoperatively
Change in employment statusFrom baseline to 1 year postoperatively
Change in Duke Activity Status Index scoreFrom baseline to 4 weeks postoperatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026